NVO
Novo Nordisk A/S
Novo Nordisk A/S historical holders
total: 8
Dodge & Cox Stock Fund Novo Nordisk A/S transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q1
Dodge & Cox Stock Fund has been an institutional investor in Novo Nordisk A/S (NVO) since 2026 Q1. According to 2026 Q1 report, Dodge & Cox Stock Fund holds 15,240,800 shares with a market value of roughly $560.10M representing 0.49% of their equity portfolio. The fund/company first acquired NVO in 2026 Q1, initially purchasing about 15.24M shares.
Does Dodge & Cox Stock Fund still hold NVO?
Yes, Dodge & Cox Stock Fund continues to hold Novo Nordisk A/S (NVO). According to their 2026 Q1 report, they maintain a position of 15,240,800 shares valued at approximately $560.10M, representing 0.49% of their equity portfolio.
When did Dodge & Cox Stock Fund first invest in NVO?
Dodge & Cox Stock Fund first invested in Novo Nordisk A/S (NVO) in 2026 Q1 at the reported quarter-end price of $36.75 per share, acquiring 15,240,800 shares in their initial purchase.
What is Dodge & Cox Stock Fund's average cost basis for NVO?
Based on historical transaction data, Dodge & Cox Stock Fund's estimated cost basis for Novo Nordisk A/S (NVO) is approximately $36.75 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $36.75
NVO transactions history by Dodge & Cox Stock Fund
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.49%
|
15,240,800
|
$36.75
|
$560,099,400
|
new
|
+0.49%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.